Magstream and OC Sensor quantitative immunochemical faecal occult blood tests (IFOBT) have shown better performances than guaiac (G) tests in colorectal cancer screening, however Magstream and OC Sensor have never been compared. We hypothesized that similar performances could be observed with Magstream and OC Sensors, provided a similar cut-off (expressed in concentration of haemoglobin in the stools) is used. We performed a literature-based indirect comparison between these tests, taking into account the cut-off, the number of samples, and the way they were combined (I 2þ : at least one positive sample of 2; I 2þþ : both positive samples; I 1 : only one sample). Six studies conducted in general average-risk populations were included in this review. For each [test] Ã [cut-off ], positivity rate (PR) decreased and predictive positive value (PPV) increased from I 2þ to I 1 and I 2þþ. For similar PR, PPV with OC Sensor was greater than with Magstream. This could be due to factors other than the test, because PPVs associated with GFOBT in studies evaluating OC Sensor were greater than PPVs associated with GFOBT in the study evaluating Magstream. Direct comparison between Magstream and OC Sensor is needed to confirm the suspected superiority of OC Sensor. Downloaded from Ã results of subsequent rounds were provided in the paper but not included in our review ÃÃ among participants ÃÃÃ without dietary restriction, nor rehydration (PCT: paired controlled trial; RCT: randomized controlled trial) ÃÃÃ study was undertaken among asymptomatic patients who underwent screening colonoscopy
INTRODUCTION
T he efficacy of guaiac faecal occult blood test (GFOBT) screening programmes in reducing colorectal cancerspecific mortality is established. 1 Magstream (Fujirebio, Japan) and OC Sensor (Eiken Chemical, Japan) quantitative immunochemical FOBTs (IFOBTs) showed better performances than GFOBTs in average-risk population settings. 2 -5 These IFOBTs have never been compared in general average-risk populations. We therefore conducted a literature review, as a preliminary indirect comparison of the performances of Magstream and OC Sensor I-FOBTs, in general average-risk populations, taking into account the cut-off and the number of samples.
MATERIAL AND METHODS
A PubMed literature search was performed on 01/05/2011, using the keywords 'immunochemical test and (threshold or cut-off ) and colorectal cancer', limited to articles in English, and excluding reviews and comments. Of the 38 articles retrieved, seven independent articles evaluated at least the performance of OC Sensor or Magstream in general average-risk populations, taking into account the cut-off and number of samples. 3 -9 Of these one article was excluded because of a high positivity rate associated with GFOBT, suggesting a specific study population. 9 Details of the study characteristics and selection processes are given in the appendices.
We compared the positivity rates (PR), and positive predictive values (PPV) of FOBTs for detection of invasive cancers or advanced neoplasias (invasive cancers or highrisk adenomas) according to cut-off and number of samples.
When not published, PRs were derived from colonoscopy rates and global adherence to colonoscopy for a positive FOBT. Only the first rounds of screening results were included. Analysis considering the IFOBT as positive if both samples were positive was denoted as I 2þþ , if at least one of two samples was positive as I 2þ , and when only one sample was performed as I 1 .
RESULTS
Four studies evaluated the OC Sensor, 3, 4, 6, 7 and two the Magstream. 5, 8 Three studies also used the GFOBT Hemoccult II. 3 -5 Subjects included were aged 50-69 in the two Italian studies 6, 7 and 50-74 in the two French studies and the two Dutch studies. 3 -5,8 Sex ratio was similar in all studies. Colonoscopy rates in case of a positive test varied from 79% to 94%.
For both Magstream and OC Sensor IFOBTs, using two samples led to a decrease in PR in I 2þþ analyses, but an Figures 1a and 1b plot the PPVs against the PR for detection of invasive cancers or advanced neoplasias. For the same PR, the PPVs for detection of invasive cancers for the Magstream in one study 5 were smaller than that of the OC Sensor, but were similar in another study. 8 In both studies the PPVs of Magstream for detection of advanced neoplasias were smaller than for the OC Sensor in all studies except one study conducted in Italy. 6 For both Magstream and OC Sensor, continuations between points for I 1 , I 2þ or I 2þþ analyses were observed. The fitted curves showed slightly better performances (greater PPV for the same PR) with OC Sensor than Magstream. 4, 7 
DISCUSSION
This literature-based indirect comparison showed slightly better performances with OC Sensor than Magstream IFOBTs, especially for detection of advanced neoplasias. For each test, our results suggest that one-sample IFOBT (I 1 ) could provide similar performances to two-sample IFOBT (I 2þ ) in average-risk population provided that a different cut-off is chosen. This is in accordance with results of Park et al., 9 and is of importance because using only one sampling could improve participation and reduce costs.
Our approach does have several limits. First, the PR and PPV depend on the diagnostic accuracy of the test, but also on the prevalence of targeted lesions. Whilst colorectal cancer incidence is similar in the countries involved in these studies, prevalence of high-risk adenomas is unknown. Difference in prevalence could additionally result from difference in the definition of lesions. Not all studies included adenomas with villous patterns in the definition of advanced neoplasias, however, small adenomas with villous patterns represent only a minor portion of highrisk adenomas detected by FOBTs. 3 Furthermore, considerable variations are found in both colonoscopy results 10 and pathological assessment of advanced neoplasias. 11 It is not possible to determine which of the differences in global indicators of efficacy (such as PR or PPV) observed between tests were due to factors other than the performance of the test itself. Indeed considerable variations are described within one test, for both GFOBT and IFOBT. For example, in France, the PR of the GFOBT programme varied between departments from 1.9% to 3.7% in the first round. The PPV for detection of colorectal cancers (including intramucosal cancers) varied between 6.5% and 16.6%. 12 Similar variations were observed using the OC Sensor test in one Italian study, where four regions were included; PPV varied between 4.5% and 5.5% for detection of invasive cancers, and between 29.9% and 37.1% for detection of advanced neoplasias. 6 Differences between IFOBTs could be due to unmeasured confounding factors. Performance of GFOBT was higher in the studies evaluating OC Sensor in the Netherlands, 3, 4 than in the study evaluating Magstream in France. 5 In addition, performance of the IFOBTs is affected by the delay between sampling and analysis and the temperature of storage. 13 The superiority of IFOBT over GFOBT is now proven, and the next step should be the comparison between IFOBTs. Our review demonstrates that indirect comparison between the crude performances lacks reliability. Direct comparisons of the performances of quantitative immunochemical FOBTs are necessary, using a paired design in which all subjects would undergo both IFOBTs, or a comparison of two groups of subjects with random allocation of IFOBTs. These comparisons should be designed and conducted to ensure that there is no confounding due to the analysis of tests (temperature and delay of storage), and standardize the definition of targeted lesions, including reproducibility of histological examination. 
